Search results
9 lip 2019 · According to the current study, the global burden of sleep apnoea is three to nine times higher than that presented in the FIRS report. These prevalence estimates even exceed those for chronic obstructive pulmonary disease and asthma. Another important aspect to consider is the link between sleep apnoea and cardiometabolic disease.
9 lip 2019 · Our estimates suggest that nearly 1 billion adults aged 30–69 years worldwide could have obstructive sleep apnoea, and the number of people with moderate to severe obstructive sleep apnoea, for which treatment is generally recommended, is estimated to be almost 425 million.
OSA affects nearly 1 billion individuals worldwide and is characterised by repetitive upper-airway collapse during sleep, resulting in intermittent hypoxaemia and sleep fragmentation. OSA is associated with various cardiovascular diseases and conditions, including hypertension, atrial fibrillation, heart failure, and stroke.
9 cze 2021 · Sleep apnoea is associated with an increased risk of cardiovascular mortality and all-cause sudden death, with a marginally significant dose–response relationship, where those with severe sleep apnoea are at the highest risk of mortality.
6 paź 2022 · One literature review says sleep apnea increases the risk of heart failure by 140%, the risk of stroke by 60%, and the risk of coronary heart disease by 30%. Around 38,000 people die from heart disease and sleep apnea each year. The Health Effects of Sleep Apnea.
14 wrz 2020 · Severe obstructive sleep apnoea has been associated with a 1.9-times increased risk in all-cause mortality and 2.65-times increased risk of cardiovascular mortality . Previous cohort studies have shown female patients to have a lower morbidity and mortality rate than males [ 3 , 4 ].
Objectives: Over 1 billion individuals worldwide experience some form of sleep apnoea, and this number is steadily rising. Obstructive sleep apnoea (OSA) can negatively influence one's quality of life and potentially increase mortality risk.
